Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study
In: Journal of clinical oncology, Jg. 38 (2020-02-10), Heft 5, S. 462-471
Online
serialPeriodical
Zugriff:
Titel: |
Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study
|
---|---|
Autor/in / Beteiligte Person: | Stroes, Charlotte I. ; Schokker, Sandor ; Creemers, Aafke ; Molenaar, Remco J. ; Hulshof, Maarten C. C. M. ; van der Woude, Stephanie O. ; Bennink, Roel J. ; Mathôt, Ron A. A. ; Krishnadath, Kausilia K. ; Punt, Cornelis J. A. ; Verhoeven, Rob H. A. ; van Oijen, Martijn G. H. ; Creemers, Geert-Jan ; Nieuwenhuijzen, Grard A. P. ; van der Sangen, Maurice J. C. ; Beerepoot, Laurens V. ; Heisterkamp, Joos ; Los, Maartje ; Slingerland, Marije ; Cats, Annemieke ; Hospers, Geke A. P. ; Bijlsma, Maarten F. ; van Berge Henegouwen, Mark I. ; Meijer, Sybren L. ; van Laarhoven, Hanneke W. M. ; School, Graduate ; Oncology ; AGEM - Re-generation and cancer of the digestive system ; APH - Methodology ; APH - Quality of Care ; CCA - Cancer Treatment and Quality of Life ; Radiotherapy ; Radiology and Nuclear Medicine ; AGEM - Amsterdam Gastroenterology Endocrinology Metabolism ; CCA -Cancer Center Amsterdam ; Pharmacy ; AGEM - Digestive immunity ; AGEM - Endocrinology, metabolism and nutrition ; Gastroenterology and Hepatology ; Center of Experimental and Molecular Medicine ; Surgery ; Pathology |
Link: |
|
Zeitschrift: | Journal of clinical oncology, Jg. 38 (2020-02-10), Heft 5, S. 462-471 |
Veröffentlichung: | 2020 |
Medientyp: | serialPeriodical |
ISSN: | 3180-9243 (print) ; 0732-183X (print) ; 1527-7755 (print) |
DOI: | 10.1200/jco.19.01814 |
Sonstiges: |
|